Sandalwood China E-Commerce Data shows COVID-related drug sales on JD reached 96.93 million RMB (around 13.91 million USD) in last week of Nov, representing a 465.02% y/y growth compared to 2021. Sales of cold and cough medicine grew 380.18% y/y and reached 60.17 million RMB (around 8.64 million USD), whereas Antipyretic and Analgesia grew 694.82% y/y and reached 36.77 million RMB (around 5.28 million USD).
COVID-related medical equipment sales grew 97.6% y/y on JD in the same period and reached 72.35 million RMB (10.38 million USD), among which Oxygen Machine/Bags/Bottles grew 88.65% y/y to 67.25 million RMB (around 9.65 million USD) and Oximeter grew 427.62% y/y to 5.1 million RMB (around 731.8k USD).
The above data is published in Sandalwood China Coronavirus Impact Analysis Live Report, which monitors real-time COVID situation impact on key sectors including luxury, housing, hotel, restaurant, automobile, e-commerce etc. in China. Stay tuned!
To subscribe, contact us at service@sandalwoodadvisors.com.
How is Temu Performing 3 Months Into Launch?
Live Report:China Coronavirus Impact Analysis